GLP-1s, a popular class of weight loss and diabetes drugs, can hinder the safety of a common gastroenterology procedure, according to a study published in Gastrointestinal Endoscopy. The researchers — ...
Encountering retained gastric contents during esophagogastroduodenoscopy (EGD) is more common in patients taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs) but rarely leads to procedure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results